New life science company LQT Therapeutics grabs seed funding

Laval, Quebec's LQT Therapeutics, a new life science company focused on treating Long QT Syndrome, has raised C$1.8 million in a seed-stage financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this